Practice Expertise

  • Health & Life Sciences
  • DEA Compliance & Litigation
  • FDA Regulatory Practice
  • Health Care Transactions

Areas of Practice

  • DEA Compliance & Litigation
  • FDA Regulatory Practice
  • Health & Life Sciences
  • Health Care Transactions
  • Health & Life Sciences
  • Pharmacy
  • Pharmacy, Drug and Device
  • Provider and Physician Groups
  • Provider/Physician Groups
  • Specialty Pharmacy
  • Telehealth
  • Wholesale Drug and Device Distribution
  • View More

Profile

Collegial, responsive, relationship-driven health care counsel

Nick Meza advises health care businesses, including retail, independent, mail-order and specialty pharmacies, pharmacy benefits managers (PBM), pharmacy hubs, wholesale drug distributors, and drug and device manufacturers. Nick's clients also include hospitals, physician/oncology groups and integrated behavioral health practices. With a master’s degree in public health, policy and administration and prior clinical work experience, Nick brings broad knowledge of the health care industry to the legal advice he provides. He focuses on:

  • Health care regulatory compliance
  • Health care transactions
  • Representing licensed professionals and entities before administrative boards

Clients rely on the responsiveness and collegiality that Nick and his team bring to the legal solutions they develop. Nick is known for providing practical legal and business solutions for health care clients. He is effective at building meaningful relationships with business partners and regulators to arrive at creative and compliant business solutions.

Bar Admissions

  • Arizona

Education

  • Arizona State University Sandra Day O'Connor College of Law (J.D., 2013)
    • Arizona State Law Journal, technology editor
    • William H. Pedrick Scholar; Hon. Valdemar A. Cordova Scholar
    • Minority Corporate Counsel Association (MCCA) Lloyd M. Johnson, Jr. Scholar
    • CALI Award (Legal Method & Writing, Public Health Law, Health Care Fraud)
  • The University of Arizona (B.S., cum laude, 2006)
    • Major: Health Sciences
  • The University of Arizona (M.P.H., 2008)
    • Master of Public Health, Policy and Administration
    • Project EXPORT Fellow
    • Hispanic Alumni Association Outstanding Graduate Student – Excellence in Leadership and Academics

Areas of Practice

  • DEA Compliance & Litigation
  • FDA Regulatory Practice
  • Health & Life Sciences
  • Health Care Transactions
  • Health & Life Sciences
  • Pharmacy
  • Pharmacy, Drug and Device
  • Provider and Physician Groups
  • Provider/Physician Groups
  • Specialty Pharmacy
  • Telehealth
  • Wholesale Drug and Device Distribution

Professional Career



Articles

  • "Florida Pharmacy Owner Convicted in $174 Million Telemedicine Fraud Scheme"
  • "Hot Topics in Pharmacy Law"
  • "New York Court Overturns Multiple Convictions Against Pharmacist"
  • "Overview of State Updates in Central Fill & Shared Services"
  • "Pharmacy 101"
  • "Specialty Pharmacy and the Law"
  • "Texas's Southern District Dismisses Pharmacist's False Claims Act Suit Against Walgreens"
  • "The Art of the [Health Care] Deal: Just like any other deal… NOT!"
  • "Updates and Issues in the Shared Services and Central Fill Space"
  • "Updates in Pharmacy Law"
  • 2018 Farm Bill, Technician Ratios, and Hazardous Waste Rules: Hot Topics in Pharmacy Law
  • A New Approach for Clarity in the Determination of Protected Concerted Activity Online
  • A Welcome Goodbye: Congress Repeals $2,010 Therapy Cap
  • After Years of Silence, New York Proposes New Rule Addressing Central Fill Arrangements
  • Alabama Board of Pharmacy Imposing 3:1 Technician to Pharmacist Ratio on Non-Resident Pharmacies
  • Alabama Designates Gabapentin as a Schedule V Drug
  • Applications Now Available for Alaska's New Licensing Categories and Prescription Standards
  • Are You Interested in the FDA's Guidance on Outsourcing Facilities? Your Time to Comment Is Ending Soon!
  • Are You Ready for Alabama’s New Designated Representative Requirements?
  • Board of Pharmacy Responses to COVID-19 Outbreak - UPDATED
  • California Passes Two Drug Pricing Transparency Laws
  • Fifth PREP Act Declaration Amendment Expands Eligible COVID-19 Vaccination Providers
  • Fourth Circuit Finds Compliance with FDA Regulatory Requirement Not a "Prerequisite to Payment" to Establish Element of Falsity under the False Claims Act
  • Georgia Board of Pharmacy Continues to Review Licensure Requirements for Pharmacists
  • Hot Off the Press: Mississippi Board of Pharmacy Files Proposed Rule on Shared Pharmacy Services
  • How Far We Have Come. How Far We Have Yet To Go.
  • Information and Guidance for Young Doctors: Navigating the Medical Landscape in the Early Years of Practice
  • Is Your Fitbit FDA-Legit?
  • Kansas Now Requires Non-resident Pharmacies to Designate a Kansas-licensed PIC
  • Kentucky Board of Pharmacy Continues to Research and Review Proposed Non-Resident Pharmacy Permit Regulations
  • Kentucky Board of Pharmacy Regulation Committee Proposes New Requirement of Licensure for All Out-of-State Pharmacists
  • Kentucky Proposes First-in-Nation Non-Resident Pharmacist License—What’s Next?
  • Kentucky Withdraws Controversial Non-Resident Pharmacist License Regulation
  • Legal Responses to Communal Rejection in Emergencies, Public Health and the Law
  • Mississippi Board of Pharmacy Approves Final Rule on Shared Pharmacy Services with Minor Modifications
  • Nevada Legislature Rejects Board of Pharmacy’s Licensing Requirement for Out-of-State Pharmacists
  • Nevada Seeks Formal AG Opinion Regarding Licensure for Out-of-State Pharmacists
  • Nevada to Require Out-of-State Pharmacists that Dispense or Compound for Nevada Patients to Hold a Nevada Pharmacist’s License
  • New Limitations on Chain Pharmacy Quotas in California
  • New York Abandons Proposed Rule Addressing Central Fill Arrangements, Will Seek Statutory Change
  • New York Medicaid Limits In-Office Dispensing Reimbursement for AIDS and Cancer Protocols
  • Planning for Preparedness and Response: COVID-19 Response for the Health and Life Sciences Industry
  • Revised Amendments to Texas Central Fill Rule Address Concerns for Misinterpretation
  • Second Shot Across the Bow: FDA Issues Warning Letters to 15 CBD Companies
  • Texas Board of Pharmacy Sends Central Fill Amendment Back for Redraft but Signals Approval
  • Texas Board of Pharmacy to Review Central Fill Rules for Potential Change
  • The Legal Implications of HIPAA Privacy and Public Health Reporting for Correctional Facilities
  • The Mifepristone Battle Enters a New Phase 
  • Washington Eliminates Technician to Pharmacist Ratio
  • ​HHS Proposes New Regulations Prohibiting Discrimination Against Transgender Individuals
  • “The Changing Landscape of Specialty Legislation”

Seminar

  • 2018 American Society for Pharmacy Law Fall Meeting
  • 2018 Pharmacy Law Symposium
  • 2019 Pharmacy Law Symposium
  • 2021 Pharmacy Law Symposium
  • 2022 Pharmacy Law Symposium
  • 2023 Pharmacy Law Symposium
  • 2024 Pharmacy Law Symposium
  • Arizona Society of Healthcare Attorney (AzSHA) Health Law Conference
  • Business Law Training | The Art of the [Health Care] Deal: Just like any other deal… NOT!
  • Issues Pertaining to Shared Services & Central Fill Arrangements
  • Virtual "Mini" Pharmacy Law Symposium
  • What Every GC, Board, and Corporation Needs to Know About Diversity, Equity and Inclusion - Part Two: A Call To Action

Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.